Roivant Sciences’ $200 Million Common Shares Offering

Leila Ahmed
Tagged:

Davis Polk & Wardwell and Conyers Dill & Pearman advised Roivant Sciences Ltd. on the offering. Cooley advised Immunovant on the transaction.Roivant Sciences Ltd. (Nasdaq:ROIV) announced a…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now